MyAverix Finance
SHG · Healthcare
Zhejiang Shouxiangu Pharm Co (603896)
Biotechnology
Zhejiang Shouxiangu Pharm Co (603896) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $3.73B, P/E ratio is 27.23, net margin is 21.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603896
Zhejiang Shouxiangu Pharm Co (603896) — FAQ
What is Zhejiang Shouxiangu Pharm Co's market cap?
Zhejiang Shouxiangu Pharm Co (603896) has a reported market cap of $3.73B (data as of 2026-03-29).
What is 603896's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Shouxiangu Pharm Co (603896) is 27.23 (data as of 2026-03-29).
Does Zhejiang Shouxiangu Pharm Co pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Shouxiangu Pharm Co (603896). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Shouxiangu Pharm Co in?
Zhejiang Shouxiangu Pharm Co (603896) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603896 listed on?
603896 is listed on SHG.
What is Zhejiang Shouxiangu Pharm Co's net margin?
Zhejiang Shouxiangu Pharm Co (603896) reports a net margin of 21.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.